Secor Capital Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-41,269
| Closed | -$120K | – | 596 |
|
|
2018
Q4 | $120K | Sell |
41,269
-82,027
| -67% | -$239K | 0.02% | 384 |
|
|
2018
Q3 | $324K | Sell |
123,296
-45,483
| -27% | -$120K | 0.04% | 309 |
|
|
2018
Q2 | $395K | Sell |
168,779
-61,638
| -27% | -$144K | 0.03% | 358 |
|
|
2018
Q1 | $677K | Sell |
230,417
-1,425
| -0.6% | -$4.19K | 0.06% | 294 |
|
|
2017
Q4 | $635K | Buy |
231,842
+12,993
| +6% | +$35.6K | 0.03% | 286 |
|
|
2017
Q3 | $742K | Sell |
218,849
-180,594
| -45% | -$612K | 0.07% | 254 |
|
|
2017
Q2 | $987K | Sell |
399,443
-10,880
| -3% | -$26.9K | 0.09% | 227 |
|
|
2017
Q1 | $931K | Hold |
410,323
| – | – | 0.1% | 208 |
|
|
2016
Q4 | $870K | Buy |
410,323
+26,352
| +7% | +$55.9K | 0.11% | 203 |
|
|
2016
Q3 | $1.29M | Buy |
383,971
+242,707
| +172% | +$813K | 0.14% | 179 |
|
|
2016
Q2 | $444K | Buy |
141,264
+31,111
| +28% | +$97.8K | 0.06% | 371 |
|
|
2016
Q1 | $367K | Sell |
110,153
-94,209
| -46% | -$314K | 0.05% | 344 |
|
|
2015
Q4 | $723K | Buy |
204,362
+167,374
| +453% | +$592K | 0.2% | 143 |
|
|
2015
Q3 | $186K | Buy |
+36,988
| New | +$186K | 0.06% | 402 |
|
|
2014
Q1 | – | Sell |
-60,054
| Closed | -$507K | – | 468 |
|
|
2013
Q4 | $507K | Buy |
+60,054
| New | +$507K | 0.2% | 200 |
|